5.3
CVE-2026-21974
- EPSS 0.03%
- Veröffentlicht 20.01.2026 21:56:36
- Zuletzt bearbeitet 29.01.2026 14:47:09
- Quelle secalert_us@oracle.com
- CVE-Watchlists
- Unerledigt
LoginVulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Oracle ≫ Life Sciences Central Designer Version7.0.1.0
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.03% | 0.092 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| secalert_us@oracle.com | 5.3 | 3.9 | 1.4 |
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
|
CWE-200 Exposure of Sensitive Information to an Unauthorized Actor
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.